News from gbi research A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 03, 2015, 07:00 ET COPD Therapeutics Market Hit $9.2 Billion in 2014 and Will Add $2 Billion by 2021, says GBI Research

Modest growth rate due to a relatively stable prevalence rate of Chronic Obstructive Pulmonary Disease (COPD) during the forecast period, says GBI...


Dec 02, 2015, 09:00 ET Cancer Treatment Pipeline Boasts Almost 6,500 Pharmaceutical Products, says GBI Research

Oncology drugs have the largest pipeline in the pharmaceutical industry, with 6,484 products in active development across all indications, says GBI...


Nov 25, 2015, 07:00 ET Success in Pharmaceuticals Requires Shrewd Life Cycle Management Strategies, says GBI Research

Developmental, commercial, and regulatory/legal strategies all play a key role in boosting the profitability of pharmaceutical products, says GBI...


Nov 24, 2015, 09:06 ET Type 1 Diabetes Mellitus Market to Grow from $4.2 Billion in 2014 to $7.1 Billion by 2021, Says GBI Research

The uptake of recently approved and pipeline premium products for Type 1 Diabetes Mellitus (T1DM), will be a key driver of market growth to 2021,...


Nov 17, 2015, 09:00 ET Non-Small Cell Lung Cancer Market to Grow from $6.9 Billion in 2014 to $10.9 Billion by 2021, Says GBI Research

The introduction of novel immune-checkpoint inhibitors, such as Opdivo and Keytruda, will drive Non-Small Cell Lung Cancer (NSCLC) therapeutics...


Nov 12, 2015, 09:00 ET Prostate Cancer Market Hit $7.6 Billion in 2014 and Will Add $6 Billion by 2021, says GBI Research

Zytiga and Xtandi's continued uptake and the approval of several premium products will drive prostate cancer market growth by 2021, says GBI Research....


Jun 29, 2015, 07:00 ET Glioblastoma Multiforme Therapeutics Market Value Will More than Double to $623 Million by 2020

Growth will hinge on DCVax-L vaccine success following early approval in Germany, says GBI Research. According to analysis from business intelligence ...


Jun 24, 2015, 12:07 ET Breast Cancer Therapeutics Market Value Will Exceed $13 Billion by 2020

Novel therapy approvals to support continued dominance of HER2 targeted drugs, says GBI Research. Analysis from business intelligence provider GBI...


Jun 23, 2015, 06:00 ET New Therapies to Drive Non-Hodgkin Lymphoma Treatment Market Value Beyond $9 Billion by 2020

Promising drug pipeline and new entrants will widen targeted and immunotherapeutic treatment options, says GBI Research. Analysis from business...


Jun 18, 2015, 07:00 ET Colorectal Cancer Treatment Market Value to Exceed $9 Billion by 2020

Increased uptake of high-priced drugs to offset the impact of generics, says GBI Research. Analysis from business intelligence provider GBI Research...


Jun 15, 2015, 10:59 ET Global Melanoma Therapeutics Market Value Forecast to Treble by 2020

Rising melanoma treatment population, evolving therapy algorithms, and continued uptake of new market entrants to drive growth, says GBI Research....


Jun 12, 2015, 07:00 ET Treatment Market Value for Attention-Deficit Hyperactivity Disorder to Exceed $13 Billion by 2020

Broadened diagnostic criteria and growing adult prevalence to drive market growth, despite patent expirations, says GBI Research. Analysis from...


Jun 08, 2015, 11:47 ET Rheumatoid Arthritis Treatment Market Value to Grow Modestly to $19 Billion by 2020

The approval of revolutionary biological therapies has triggered unparalleled market growth, says GBI Research. Analysis from business intelligence...


Jun 03, 2015, 10:13 ET Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts

The treatment pipeline for Acute Myeloid Leukemia (AML) addresses clinical gaps in the market, says GBI Research. Analysis from business intelligence ...


Jun 01, 2015, 12:20 ET New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market

Novel treatments entering the squamous cell carcinoma segment will drive growth, says GBI Research. The Non-Small Cell Lung Cancer (NSCLC) treatment...


May 29, 2015, 09:33 ET Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations

Asthma treatment could see significant step forward aspersonalized treatments enter arena, says GBI Research. Despite generic erosion facing several...